  | Belhocine, T., Pierard, G., Frühling, J., Letesson, G., Bolle, S., Hustinx, R., Dargent, J.-L., Flamen, P., & Rigo, P. (2006). Clinical added-value of 18FDG PET in neuroendocrine-merkel cell carcinoma. Oncology Reports, 16 (2), 347-352. doi:10.3892/or.16.2.347  Peer Reviewed verified by ORBi |
Rigo, P., Hustinx, R., & Bury, T. (2006). PET and PET/CT Imaging in Lung Cancer. In P. Valk, D. Delbeke, D. Bailey, D. Townsend, ... M. Maisey (Eds.), Positron Emission Tomography - Clnical practice (pp. 89-106). Springer. Peer reviewed |
 | Rigo, P., Hustinx, R., & Bury, T. (2006). PET imaging in lung cancer. In P. E. Valk, D. Delbeke, D. L. Bailey, D. W. Townsend, ... M. M. Maisey (Eds.), Positron emission tomography (pp. 89-106). Londres, United Kingdom: Springer. |
 | Jerusalem, G., Hustinx, R., & Rigo, P. (2006). PET and PET/CT imaging in lymphomas. In P. E. Valk, D. Delbeke, D. L. Bailey, D. W. Townsend, ... M. N. Maisey, Positron emission tomography (pp. 125-145). Londres, United Kingdom: Springer. |
 | Depas, G., De Barsy, C., Jerusalem, G., Hoyoux, C., DRESSE, M.-F., Fassotte, M.-F., Paquet, N., Willems, J., Rigo, P., & Hustinx, R. (January 2005). F-18-FDG PET in children with lymphomas. European Journal of Nuclear Medicine and Molecular Imaging, 32 (1), 31-38. doi:10.1007/s00259-004-1604-z Peer Reviewed verified by ORBi |
  | Couturier, O., Luxen, A., Chatal, J.-F., Vuillez, J.-P., Rigo, P., & Hustinx, R. (August 2004). Fluorinated tracers for imaging cancer with positron emission tomography. European Journal of Nuclear Medicine and Molecular Imaging, 31 (8), 1182-1206. doi:10.1007/s00259-004-1607-9 Peer Reviewed verified by ORBi |
 | Rigo, P., Hustinx, R., & Bury, T. (2004). PET in lung cancer. In D. L. Bailey, D. W. Townsend, P. E. Valk, ... M. N. Maisey, Positron emission tomography. Principles and practice (pp. 517-534). Springer. |
 | Alberini, J. L., Belhocine, T., Hustinx, R., Daenen, F., & Rigo, P. (October 2003). Whole-body positron emission tomography using fluorodeoxyglucose in patients with metastases of unknown primary tumours (CUP syndrome). Nuclear Medicine Communications, 24 (10), 1081-1086. doi:10.1097/00006231-200310000-00008 Peer Reviewed verified by ORBi |
 | Belhocine, T., Kridelka, F., Thille, A., De Barsy, C., Foidart-Willems, J., Hustinx, R., & Rigo, P. (June 2003). Staging of primary cervical cancers: the role of nuclear medicine [letter to the editor]. Critical Reviews in Oncology/Hematology, 46 (3), 275-284. doi:10.1016/S1040-8428(03)00027-1 Peer Reviewed verified by ORBi |
 | Jerusalem, G., Beguin, Y., Fassotte, M.-F., Belhocine, T., Hustinx, R., Rigo, P., & Fillet, G. (2003). Early detection of relapse by whole-body positron emission tomography in the follow-up of patients with Hodgkin's disease. Annals of Oncology, 14 (1), 123-30. doi:10.1093/annonc/mdg011 Peer Reviewed verified by ORBi |
 | Paquet, P., Hustinx, R., Rigo, P., & Pierard, G. (2003). Malignant melanoma. In P. Oehr, H. J. Biersack, ... E. R. Coleman (Eds.), PET and PET-CT in Oncology (pp. 259-265). Heidelberg, Germany: Srpinger. |
Jerusalem, G., Rigo, P., & Israel, O. (2003). PET and PET/CT of lymphoma. In G. K. von Schulthess (Ed.), Clinical Molecular Anatomic Imaging (pp. 350-361). Lippincott Williams and Wilkins. |
Jerusalem, G., & Rigo, P. (2003). PET Imaging in Lymphoma. In P. E. Valk, D. L. Bailey, D. W. Townsend, ... M. N. Maisey (Eds.), Positron emission tomography (pp. 547-557). Springer. |
 | Belhocine, T., Thille, A., Fridman, V., Albert, A., Seidel, L., Nickers, P., Kridelka, F., & Rigo, P. (October 2002). Contribution of whole-body (18)FDG PET imaging in the management of cervical cancer. Gynecologic Oncology, 87 (1), 90-97. doi:10.1006/gyno.2002.6769 Peer Reviewed verified by ORBi |
 | Belhocine, T., Steinmetz, N., Hustinx, R., Bartsch, P., Jerusalem, G., Seidel, L., Rigo, P., & Green, A. (September 2002). Increased uptake of the apoptosis-imaging agent (99m)Tc recombinant human annexin V in human tumors after one course of chemotherapy as a predictor of tumor response and patient prognosis. Clinical Cancer Research, 8 (9), 2766-2774. Peer Reviewed verified by ORBi |
 | Belhocine, T., Willems, J., Rigo, P., Najjar, F., Thiry, A., Quatresooz, P., & Hustinx, R. (August 2002). Fluorodeoxyglucose positron emission tomography and somatostatin receptor scintigraphy for diagnosing and staging carcinoid tumours: correlations with the pathological indexes p53 and Ki-67. Nuclear Medicine Communications, 23 (8), 727-734. doi:10.1097/00006231-200208000-00005 Peer Reviewed verified by ORBi |
 | Belhocine, T., Pierard, G., De Labrassinne, M., Lahaye, T., & Rigo, P. (2002). Staging of regional nodes in AJCC stage I and II melanoma: 18FDG PET imaging versus sentinel node detection. Oncologist, 7 (4), 271-8. doi:10.1634/theoncologist.7-4-271 Peer Reviewed verified by ORBi |
 | SakalihasanN, N., Van Damme, H., Gomez, P., Rigo, P., Lapiere, C. M., Nusgens, B., & Limet, R. (2002). Positron emission tomography (PET) evaluation of abdominal aortic aneurysm (AAA). European Journal of Vascular and Endovascular Surgery, 23 (5), 431-436. doi:10.1053/ejvs.2002.1646 Peer Reviewed verified by ORBi |
 | Belhocine, T., Kaye, O., Delanaye, P., Corman, V., Baghaie, M., Deprez, M., Daenen, F., De Barsy, C., Beckers, C., Gomez, P., Hustinx, R., Foidart-Willems, J., Demonty, J., Malaise, M., & Rigo, P. (2002). Maladie de Horton et atteintes arterielles extratemporales: utilite de la tomographie par emission de positons au 18FDG. A propos de trois observations et d'une revue de la litterature. Revue de Médecine Interne, 23 (7), 584-91. doi:10.1016/S0248-8663(02)00620-3 Peer Reviewed verified by ORBi |
 | Belhocine, T., Pierard, G., Gielen, J.-L., Daenen, F., De Barsy, C., Arrese Estrada, J., Lahaye, T., & Rigo, P. (2002). Gamma-probe-directed lymphatic mapping and sentinel lymphadenectomy in primary cutaneous melanoma. Dermatology, 204 (4), 355-61. doi:10.1159/000063385 Peer Reviewed verified by ORBi |
 | LANCELLOTTI, P., Benoit, T., Rigo, P., & PIERARD, L. (November 2001). Dobutamine Stress Echocardiography Versus Quantitative Technetium-99m Sestamibi Spect for Detecting Residual Stenosis and Multivessel Disease after Myocardial Infarction. Heart, 86 (5), 510-5. doi:10.1136/heart.86.5.510 Peer Reviewed verified by ORBi |
 | Najjar, F., Hustinx, R., Jerusalem, G., Fillet, G., & Rigo, P. (August 2001). Positron Emission Tomography (PET) for Staging Low-Grade Non-Hodgkin's Lymphomas (NHL). Cancer Biotherapy and Radiopharmaceuticals, 16 (4), 297-304. doi:10.1089/108497801753131372 Peer Reviewed verified by ORBi |
 | Jerusalem, G., Beguin, Y., Najjar, F., Hustinx, R., Fassotte, M.-F., Rigo, P., & Fillet, G. (2001). Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL). Annals of Oncology, 12 (6), 825-30. doi:10.1023/A:1011169332265 Peer Reviewed verified by ORBi |
 | Albérini, J.-L., Belhocine, T., Daenen, F., Hustinx, R., & Rigo, P. (2001). Apport de la tomographie par émission de positons pour la détection des tumeurs primitives lors de la découverte de métastases. Bulletin du Cancer, 88 (5), 518-519. Peer Reviewed verified by ORBi |
 | Jerusalem, G., Belhocine, T., Silvestre, R.-M., Sautois, B., Hustinx, R., Beguin, Y., Fillet, G., & Rigo, P. (2001). Place de la tomographie d'émission de positons dans le suivi thérapeutique du cancer du sein. Médecine Nucléaire: Imagerie Fonctionnelle et Métabolique, 25 (6), 341-346. Peer reviewed |
 | Jerusalem, G., Beguin, Y., Fassotte, M.-F., Najjar, F., Paulus, P., Rigo, P., & Fillet, G. (2001). Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease. Haematologica, 86 (3), 266-73. Peer Reviewed verified by ORBi |
Belhocine, T. Z., Daenen, F., Duysinx, B., Bury, T., & Rigo, P. (August 2000). Typical Appearance of Mesothelioma on an F-18 Fdg Positron Emission Tomograph. Clinical Nuclear Medicine, 25 (8), 636. doi:10.1097/00003072-200008000-00020 Peer Reviewed verified by ORBi |
Bury, T., & Rigo, P. (April 2000). Intérêt de la tomographie à émission de positons dans la prise en charge du cancer broncho-pulmonaire. Revue de Pneumologie Clinique, 56 (2), 125-31. Peer Reviewed verified by ORBi |
 | Daenen, F., Hustinx, R., Belhocine, T., Focan, C., Honore, P., & Rigo, P. (February 2000). Tomographie a emission de positons au 18FDG et adenocarcinome pancreatique. Revue Médicale de Liège, 55 (2), 89-94. Peer reviewed |
 | Brasseur, E., PHILIPS, J.-C., BELHOCINE, T., & Rigo, P. (January 2000). Mise au point d'une hyperparathyroidie primitive: apport de la scintigraphie. Revue Médicale de Liège, 55 (1), 39-44. Peer reviewed |
 | Jerusalem, G., Beguin, Y., Fassotte, M.-F., Najjar, F., Paulus, P., Rigo, P., & Fillet, G. (2000). Persistent tumor 18F-FDG uptake after a few cycles of polychemotherapy is predictive of treatment failure in non-Hodgkin's lymphoma. Haematologica, 85 (6), 613-8. Peer Reviewed verified by ORBi |
 | Jerusalem, G., Beguin, Y., Fassotte, M.-F., Belhocine, T., Najjar, F., Hustinx, R., Rigo, P., & Fillet, G. (2000). Evaluation thérapeutique précoce par tomographie à émission de positons. Médecine et Hygiène, 58, 1629-1632. Peer Reviewed verified by ORBi |
 | Belhocine, T., Hustinx, R., Devillers, C., Daenen, F., Beckers, C., Paulus, D., & Rigo, P. (2000). PET for carcinomas of the genitourinary system. In I. Khakhali, J. Laublant, ... S. J. Goldsmith, NUCLEAR ONCOLOGY : DIAGNOSIS AND THERAPY (pp. 403-416). Londres, United Kingdom: Lippincott Williams and Wilkins. |
Bury, T., DUYSINX, B., CORHAY, J.-L., BARTSCH, P., & Rigo, P. (2000). Comment j'explore ... un cancer broncho-pulmonaire par imagerie metabolique (TEP-18-FDG). Revue Médicale de Liège, 55 (3), 178-83. Peer reviewed |
 | Paquet, P., Henry, F., Belhocine, T., Hustinx, R., Najjar, F., Pierard-Franchimont, C., Pierard, G., & Rigo, P. (2000). An Appraisal of 18-Fluorodeoxyglucose Positron Emission Tomography for Melanoma Staging. Dermatology, 200 (2), 167-9. doi:10.1159/000018357 Peer Reviewed verified by ORBi |
 | Rigo, P., Belhocine, T., Hustinx, R., & Foidart, J. (2000). TEP et tumeurs endocrines. Médecine Nucléaire: Imagerie Fonctionnelle et Métabolique, 24 (5), 275-282. Peer reviewed |
 | Hustinx, R., Paulus, P., Daenen, F., Detroz, B., Honore, P., Comhair, N., & Rigo, P. (December 1999). Intérêt de la tomographie a émission de positons dans l'évaluation des tumeurs digestives. Revue Médicale de Liège, 54 (12), 925-30. Peer reviewed |
 | Hustinx, R., Paulus, P., Daenen, F., Detroz, B., Honore, P., Comhair, N., & Rigo, P. (March 1999). Interet clinique de la tomographie a emission de positons dans la detection et le bilan d'extension des recidives des cancers colorectaux. Gastroentérologie Clinique et Biologique, 23 (3), 323-9. Peer Reviewed verified by ORBi |
 | Bury, T., Corhay, J.-L., Duysinx, B., Daenen, F., Ghaye, B., Barthelemy, N., Rigo, P., & Bartsch, P. (1999). Value of FDG-PET in detecting residual or recurrent nonsmall cell lung cancer. European Respiratory Journal, 14 (6), 1376-1380. doi:10.1183/09031936.99.14613769 Peer Reviewed verified by ORBi |
 | Najjar, F., Jerusalem, G., Paulus, P., Fillet, G., & Rigo, P. (1999). Intérêt clinique de la tomographie à émission de positons dans la détection et le bilan d'extension des lymphomes non Hodgkiniens de malignité intermédiaire ou élevée. Médecine Nucléaire: Imagerie Fonctionnelle et Métabolique, 23, 281-290. Peer reviewed |
 | Jerusalem, G., Beguin, Y., Fassotte, M.-F., Najjar, F., Paulus, P., Rigo, P., & Fillet, G. (1999). Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging. Blood, 94 (2), 429-33. doi:10.1182/blood.v94.2.429.414k26_429_433 Peer Reviewed verified by ORBi |
 | Rigo, P., Albérini, J.-L., Hustinx, R., Paulus, P., Baretto, A., & Daenen, F. (1999). Intérêt de la tomographie à émission de positons dans l'évaluation des tumeurs gastro-intestinales. Acta Endoscopica, 29 (2), 129-138. Peer reviewed |
 | Jerusalem, G., Warland, V., Najjar, F., Paulus, P., Fassotte, M. F., Fillet, G., & Rigo, P. (January 1999). Whole-Body 18f-Fdg Pet for the Evaluation of Patients with Hodgkin's Disease and Non-Hodgkin's Lymphoma. Nuclear Medicine Communications, 20 (1), 13-20. doi:10.1097/00006231-199901000-00004 Peer Reviewed verified by ORBi |
 | Paulus, P., Sambon, A., Vivegnis, D., Hustinx, R., Moreau, P., Collignon, J., Deneufbourg, J.-M., & Rigo, P. (October 1998). 18fdg-Pet for the Assessment of Primary Head and Neck Tumors: Clinical, Computed Tomography, and Histopathological Correlation in 38 Patients. Laryngoscope, 108 (10), 1578-83. doi:10.1097/00005537-199810000-00029 Peer Reviewed verified by ORBi |
 | Bury, T., BARRETO, A., Daenen, F., BARTHELEMY, N., Ghaye, B., & Rigo, P. (September 1998). Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer. European Journal of Nuclear Medicine, 9. doi:10.1007/s002590050291 Peer Reviewed verified by ORBi |
 | Paquet, P., Hustinx, R., Rigo, P., & Pierard, G. (February 1998). Malignant Melanoma Staging Using Whole-Body Positron Emission Tomography. Melanoma Research, 8 (1), 59-62. doi:10.1097/00008390-199802000-00010 Peer Reviewed verified by ORBi |
 | Hustinx, R., Paulus, P., Jacquet, N., Jerusalem, G., Bury, T., & Rigo, P. (1998). Clinical evaluation of whole-body 18F-fluorodeoxyglucose positron emission tomography in the detection of liver metastases. Annals of Oncology, 9 (4), 397-401. doi:10.1023/A:1008290027419 Peer Reviewed verified by ORBi |
 | Bury, T., Dowlati, A., Paulus, P., Corhay, J.-L., Hustinx, R., Ghaye, B., Radermecker, M., & Rigo, P. (November 1997). Whole-body 18FDG positron emission tomography in the staging of non-small cell lung cancer. European Respiratory Journal, 10 (11), 2529-34. doi:10.1183/09031936.97.10112529 Peer Reviewed verified by ORBi |
VAN DAMME, H., Pierard, L., Gillain, D., Benoit, T., Rigo, P., & Limet, R. (February 1997). Cardiac Risk Assessment before Vascular Surgery: A Prospective Study Comparing Clinical Evaluation, Dobutamine Stress Echocardiography, and Dobutamine Tc-99m Sestamibi Tomoscintigraphy. Cardiovascular Surgery, 5 (1), 54-64. doi:10.1016/S0967-2109(96)00089-0 Peer Reviewed verified by ORBi |
 | Paulus, P., Hustinx, R., Daenen, F., Comhair, N., & Rigo, P. (1997). Usefulness of 18fdg Positron Emission Tomography in Detection and Follow-up of Digestive Cancers. Acta Gastro-Enterologica Belgica, 60 (4, Oct-Dec), 278-80. Peer Reviewed verified by ORBi |
 | Rigo, P., Paulus, P., Bury, T., Jerusalem, G., Hustinx, R., Benoit, T., Larock, M.-P., & Willems, J. (1997). Clinical PET in Oncology. In H. Bergmann, A. Kroiss, ... Sinzinger H (Eds.), Radioactive Isotopes in Clinical Medicine and Research (pp. 3-14). Basel, Switzerland: Birhauser Verlag. |
Bury, T., Paulus, P., Dowlati, A., CORHAY, J.-L., Rigo, P., & Radermecker, M. (1997). Evaluation of pleural diseases with FDG-PET imaging: preliminary report. Thorax, 52 (2), 187-9. doi:10.1136/thx.52.2.187 Peer Reviewed verified by ORBi |
 | Rigo, P., Paulus, P., Kaschten, B., Hustinx, R., Bury, T., Jerusalem, G., Benoit, T., & Foidart-Willems, J. (December 1996). Oncological Applications of Positron Emission Tomography with Fluorine-18 Fluorodeoxyglucose. European Journal of Nuclear Medicine, 23 (12), 1641-74. doi:10.1007/BF01249629 Peer Reviewed verified by ORBi |
 | Bury, T., Paulus, P., Dowlati, A., Corhay, J.-L., Weber, T., Ghaye, B., Schoffers, J., Limet, R., Albert, A., Rigo, P., & Radermecker, M. (December 1996). Staging of the Mediastinum: Value of Positron Emission Tomography Imaging in Non-Small Cell Lung Cancer. European Respiratory Journal, 9 (12), 2560-4. doi:10.1183/09031936.96.09122560 Peer Reviewed verified by ORBi |
 | Bury, T., Paulus, P., Weber, T., Hustinx, R., Corhay, J.-L., Rigo, P., & Radermecker, M. (April 1996). Comment j'explore ... une suspicion de cancer broncho-pulmonaire par tomographie a émission de positrons. Revue Médicale de Liège, 51 (4), 317-9. Peer reviewed |
 | BURY, T., Dowlati, A., Paulus, P., CORHAY, J.-L., Benoit, T., Kayembe, J. M., Limet, R., Rigo, P., & RADERMECKER, M. (March 1996). Evaluation of the Solitary Pulmonary Nodule by Positron Emission Tomography Imaging. European Respiratory Journal, 9 (3), 410-4. doi:10.1183/09031936.96.09030410 Peer Reviewed verified by ORBi |
 | Bury, T., Dowlati, A., Paulus, P., Hustinx, R., Radermecker, M., & Rigo, P. (February 1996). Staging of Non-Small-Cell Lung Cancer by Whole-Body Fluorine-18 Deoxyglucose Positron Emission Tomography. European Journal of Nuclear Medicine, 23 (2), 204-6. doi:10.1007/BF01731846 Peer Reviewed verified by ORBi |
Bury, T., CORHAY, J.-L., Paulus, P., Weber, T., D'Harcour, J. B., Limet, R., Rigo, P., & Radermecker, M. (1996). Tomographie a emission de positons dans l'evaluation de l'extension ganglionnaire intrathoracique du cancer bronchique non petites cellules. Etude preliminaire chez 30 patients. Revue des Maladies Respiratoires, 13 (3), 281-286. Peer Reviewed verified by ORBi |
 | Hustinx, R., Paulus, D., Rigo, P., Yeung, H. W., Macapinlac, H. A., & Larson, S. M. (1996). Clinical PET in Oncology. France: GE Medical Systems. |
Bury, T., & Rigo, P. (1995). Apport de la tomographie à émission de positons dans la mise au point du cancer bronchique : comparaison avec l’imagerie structurelle. In M. Boiron & M. Marty (Eds.), EuroCancer 95, 1st ed (pp. 73-74). JL Eurotext. Peer reviewed |
Salmon, E., Sadzot, B., Maquet, P., Degueldre, C., Lemaire, C., Rigo, P., Comar, D., & Franck, G. (1994). Differential diagnosis of Alzheimer's disease with PET. Journal of Nuclear Medicine, 35 (3), 391-8. Peer Reviewed verified by ORBi |
de Landsheere, C., Mannheimer, C., Habets, A., Guillaume, M., Bourgeois, I., Augustinsson, L. E., Eliasson, T., Lamotte, D., Kulbertus, H., & Rigo, P. (01 May 1992). Effect of Spinal Cord Stimulation on Regional Myocardial Perfusion Assessed by Positron Emission Tomography. American Journal of Cardiology, 69 (14), 1143-9. doi:10.1016/0002-9149(92)90926-P Peer Reviewed verified by ORBi |
Larock, M. P., Cantineau, R., Legrand, V., Kulbertus, H., & Rigo, P. (1990). 99mtc-Mibi (Rp-30) to Define the Extent of Myocardial Ischemia and Evaluate Ventricular Function. European Journal of Nuclear Medicine, 16 (4-6), 223-30. doi:10.1007/BF00842772 Peer Reviewed verified by ORBi |
Guillaume, M., de Landsheere, C., Rigo, P., & Czichosz, R. (1988). Automated Production of Potassium-38 for the Study of Myocardial Perfusion Using Positron Emission Tomography. International Journal of Radiation Applications and Instrumentation. Part A, Applied Radiation and Isotopes, 39 (2), 97-107. doi:10.1016/0883-2889(88)90154-2 Peer Reviewed verified by ORBi |
Limet, R., David, J.-L., Magotteaux, P., Larock, M. P., & Rigo, P. (November 1987). Prevention of Aorta-Coronary Bypass Graft Occlusion. Beneficial Effect of Ticlopidine on Early and Late Patency Rates of Venous Coronary Bypass Grafts: A Double-Blind Study. Journal of Thoracic and Cardiovascular Surgery, 94 (5), 773-83. doi:10.1016/s0022-5223(19)36194-x Peer Reviewed verified by ORBi |
Larock, M.-P., Burguet, W., Grenade, T., Trotteur, G., MAGOTTEAUX, P., Limet, R., & Rigo, P. (01 November 1987). Usefulness of Thromboendarterectomy in Association with Coronary Artery Bypass Grafting. American Journal of Cardiology, 60 (13), 1025-9. doi:10.1016/0002-9149(87)90346-8 Peer Reviewed verified by ORBi |
Delandsheere, C. M., Raets, D., Pierard, L., Berthe, C., Legrand, V., Crochelet, L., Chapelle, J.-P., Lemaire, C., Delfiore, G., Guillaume, M., Lamotte, D., Kulbertus, H., & Rigo, P. (October 1987). Thrombolysis in anterior myocardial-infarction-effect onregionnal viability studied with positron emission tomography. Circulation, 76 (4), 5. Peer Reviewed verified by ORBi |
Legrand, V., Albert, A., Rigo, P., & Kulbertus, H. (1986). Complementary role of thallium-201 scintigraphy to predischarge exercise electrocardiography for patients stratification after a first myocardial infarction. European Heart Journal, 7 (8), 644-53, 726. doi:10.1093/oxfordjournals.eurheartj.a062118 Peer Reviewed verified by ORBi |
Legrand, V., Rigo, P., Smeets, J. P., Demoulin, J. C., Collignon, P., & Kulbertus, H. (1983). Right ventricular myocardial infarction diagnosed by 99 m technetium pyrophosphate scintigraphy: clinical course and follow-up. European Heart Journal, 4 (1), 9-19. doi:10.1093/oxfordjournals.eurheartj.a061376 Peer Reviewed verified by ORBi |
 | Legrand, V., Chevigne, M., Foulon, J., & Rigo, P. (1983). Evaluation of right-ventricular function by gated blood-pool scintigraphy. Journal of Nuclear Medicine, 24 (10), 886-93. Peer Reviewed verified by ORBi |
Legrand, V., Rigo, P., Burguet, W., Smeets, J. P., Collignon, P., & Kulbertus, H. (1982). Segmental analysis of stress thallium 201 scintigraphy for the diagnosis and localization of coronary artery disease. European Heart Journal, 3 (2), 114-21. doi:10.1093/oxfordjournals.eurheartj.a061272 Peer Reviewed verified by ORBi |
Legrand, V., & Rigo, P. (1981). L'infarctus du ventricule droit, aspects diagnostiques et therapeutiques. Revue Médicale de Liège, 36 (17), 615-21. Peer reviewed |
Smeets, J. P., Rigo, P., Legrand, V., Chevigne, M., Hastir, F., & Kulbertus, H. (1981). Prognostic value of thallium-201 stress myocardial scintigraphy with exercise ECG after myocardial infarction. Cardiology, 68 Suppl 2, 67-70. doi:10.1159/000173319 Peer Reviewed verified by ORBi |
Legrand, V., & Rigo, P. (1981). Premature opening of the pulmonary valve in right ventricular myocardial infarction. Acta Cardiologica, 36 (4), 289-93. Peer Reviewed verified by ORBi |
Smeets, J.-P., Legrand, V., Rigo, P., Demoulin, J.-C., Boland, J., de Landsheere, C., Foidart, G., Collignon, P., & Kulbertus, H. (1981). Subendocardial myocardial infarction: a follow-up study of 55 cases. European Heart Journal, 2 (1), 57-63. doi:10.1093/oxfordjournals.eurheartj.a061164 Peer Reviewed verified by ORBi |
Rigo, P., Chevigne, M., Legrand, V., Joiret-Monfort, B., & Foulon, J. (1981). Radionuclide angiography during exercise: review of methodology and results in normal subjects. Acta Cardiologica. Supplementum, 26, 87-94. Peer Reviewed verified by ORBi |